# Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia

> **NCT00646165** · PHASE1 · TERMINATED · sponsor: **Mundipharma Research Limited** · enrollment: 1 (actual)

## Conditions studied

- B-cell Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Forodesine

## Key facts

- **NCT ID:** NCT00646165
- **Lead sponsor:** Mundipharma Research Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2009-01
- **Final completion:** 2009-05
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Poor recruitment and change in development strategy
- **Last updated:** 2010-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00646165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00646165, "Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00646165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*